PLYX
Polaryx Therapeutics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$2.00
+0.50%Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.03
- EPS estimate
- -$0.04
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -45.2%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Strong Buy
- Price target
- $6.67
- PT range
- $6.00 – $7.00
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Aug 13, 2026